Vaccine Treatment and Evaluation Units: Why Support a "Ready Base" of Clinical Trial Sites?
Saved in:
| Title: | Vaccine Treatment and Evaluation Units: Why Support a "Ready Base" of Clinical Trial Sites? |
|---|---|
| Authors: | Erbelding EJ; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Marrazzo JM; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2025 Oct 10; Vol. 81 (Supplement_2), pp. S55-S58. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
